AI assistant
Sending…
BIO-RAD LABORATORIES, INC. — Director's Dealing 2020
May 1, 2020
30786_dirs_2020-05-01_83d199d1-90b8-4222-aac3-35eb4c660303.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO-RAD LABORATORIES, INC. (BIO, BIOB)
CIK: 0000012208
Period of Report: 2020-04-29
Reporting Person: RAMALINGAM AJIT (EVP, Chief Accounting Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-04-29 | Restricted Stock Units | $0 | A | 1384 | Acquired | Bio-Rad A Common Stock (1384) | Direct |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F2: The restricted stock units vest over five years at 20% per year on the yearly anniversary date of the grant.
More from BIO-RAD LABORATORIES, INC.
Regulatory Filings
2026
May 13
Regulatory Filings
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 24
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Mar 25
Proxy Solicitation & Information Statement
2026
Mar 25
Regulatory Filings
2026
Feb 19
Annual Report
2026
Feb 13